3550 General Atomics Court
Sirenas is a company with a validated drug development platform designed to bring unparalleled chemical diversity to high-value therapeutic areas. Our mission is to generate a proprietary and partnered pipeline of breakthrough drug leads. We currently specialize in the discovery and development of differentiated payloads for antibody drug conjugates and of new chemical entities in immuno-oncology.
CEO: Eduardo Esquenazi